BromAc trial in Spain

Pseudomyxoma peritonei (PMP) is a rare malignant disease characterized by the progressive and multifocal accumulation of abundant mucinous tumour tissue in the peritoneal cavity. It is generally associated with a perforated epithelial neoplasm of the appendix. The...

Your sexual health after treatment

Intimacy is often a bit of a taboo subject in our society and none more so than after illness. If your doctor spoke with you unprompted about intimacy after surgery for pseudomyxoma peritonei (or PMP) or appendix cancer, then you’re amongst the lucky ones. If...

#helpushelpyou

The current climate has presented us with many issues and one of the greatest concerns is not many of us have visited a hospital for care during the COVID-19 pandemic. Given the significant disruption that COVID-19 caused to cancer diagnosis and treatment, combined...

An evidence-based approach

The BMJ defines evidence-based medicine¹ as: “the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients” It’s a constantly evolving definition and at Pseudomyxoma Survivor, we...